🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07582289
Starting soon Observational

Labor Epidural Analgesia and Mother-Infant Bonding After Vaginal Delivery

NCT07582289 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-05-15
Last updated
2026-06-03

Condition(s) studied

Postpartum RecoveryMother-infant BondingLabor Pain

Investigational drug(s) / intervention(s)

Labor Epidural Analgesia

Labor Epidural Analgesia: Epidural analgesia administered during labor as part of routine clinical care for pain management during vaginal delivery.

Study summary

This prospective observational cohort study aims to evaluate the association between postpartum recovery quality and mother-infant bonding in women undergoing vaginal delivery. Postpartum recovery quality will be assessed using the Obstetric Quality of Recovery-10 (ObsQoR-10) questionnaire, and mother-infant bonding will be evaluated using the Postpartum Bonding Questionnaire (PBQ).

Participants will be grouped according to routine clinical labor analgesia preference: women receiving labor epidural analgesia and women not receiving epidural analgesia. Additional assessments will include postpartum pain intensity, anxiety, depressive symptoms, and birth satisfaction.

Baseline psychological assessments will be performed before delivery. The primary postpartum evaluation will be conducted between 6 and 24 hours after delivery. Exploratory follow-up assessments will be performed by telephone during postpartum week 2.

The study aims to better understand the relationship between labor analgesia, postpartum recovery, and early mother-infant bonding outcomes after vaginal delivery.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
40 Years
Healthy volunteers
No
Inclusion Criteria: * Female participants aged 18 to 40 years * Term singleton pregnancy (≥37 weeks) * Planned vaginal delivery * ASA physical status II * Ability to understand Turkish * Written informed consent Exclusion Criteria: * Contraindications to epidural analgesia including coagulopathy, anticoagulant use, infection, or increased intracranial pressure * Cesarean delivery * High-risk pregnancy * Neonatal intensive care unit requirement * Major depressive disorder * Anxiety disorder * Current psychotropic medication use

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ataturk University Erzurum Turkey (Türkiye)

More Ataturk University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07582289 on ClinicalTrials.gov ↗ ← All trials in Turkey